ArticleDrug design, development and therapy2026

Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study.

Honghan Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.